A detailed history of Semmax Financial Advisors Inc. transactions in Novavax Inc stock. As of the latest transaction made, Semmax Financial Advisors Inc. holds 366 shares of NVAX stock, worth $3,100. This represents 0.0% of its overall portfolio holdings.

Number of Shares
366
Holding current value
$3,100
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.71 - $17.11 $3,919 - $6,262
366 New
366 $4,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $662M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Semmax Financial Advisors Inc. Portfolio

Follow Semmax Financial Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Semmax Financial Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Semmax Financial Advisors Inc. with notifications on news.